Skip to main content
Log in

Development and validation of an assay method for benzene in the delgocitinib drug substance using conventional HPLC

  • Original Paper
  • Published:
Chemical Papers Aims and scope Submit manuscript

Abstract

Benzene is a highly toxic solvent that should be limited to no more than 2 ppm in drug substances, as regulated by the International Council for Harmonization guideline Q3C. We herein report an assay method for residual benzene detection in the delgocitinib drug substance using conventional high-performance liquid chromatography (HPLC). The proposed method takes advantage of the good extraction efficiency of benzene when using non-polar organic solvents, the ability of benzene to concentrate in minimum amounts of organic solvent, and the high solubility of the delgocitinib drug substance in aqueous media, resulting in salt formation as well as excellent sensitivity and selectivity. Specifically, this method uses 5 mL of 8 mol/L potassium hydroxide as an aqueous medium and 1 mL of n-hexane as organic solvent, in order to increase the resolution and sensitivity to residual benzene for HPLC. Range of the method was from 0.5 to 3 ppm according to the results of linearity, accuracy and precision, and limits of detection and quantitation of the method were 0.1 and 0.5 ppm, respectively. We expect this method to be used as a general and convenient assay of excellent sensitivity and selectivity for benzene detection, particularly when contained in water-soluble drug substances.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  • Agency for Toxic Substances and Disease Registry (ATSDR) (2007) Toxicological profile for benzene. p 438

  • Amano W, Nakajima S, Kunugi H, Numata Y, Kitoh A, Egawa G, Dainichi T, Honda T, Otsuka A, Kimoto Y, Yamamoto Y, Tanimoto A, Matsushita M, Miyachi Y, Kabashima K (2015) The Janus kinase inhibitor JTE-052 improves skin barrier function through suppressing signal transducer and activator of transcription 3 signaling. J Allergy Clin Immunol 136(3):667–677. https://doi.org/10.1016/j.jaci.2015.03.051

    Article  CAS  PubMed  Google Scholar 

  • Amano W, Nakajima S, Yamamoto Y, Tanimoto A, Matsushita M, Miyachi Y, Kabashima K (2016) JAK inhibitor JTE-052 regulates contact hypersensitivity by downmodulating T cell activation and differentiation. J Dermatol Sci 84(3):258–265. https://doi.org/10.1016/j.jdermsci.2016.09.007

    Article  CAS  PubMed  Google Scholar 

  • Berg L (1990) Separation of benzene from acetone by azeotropic distillation. US Patent 4,931,145, 5 June 1990

  • Budavari S (1996) The Merck Index: an encyclopedia of chemicals, drugs and biologicals, 12th edn. Merck and Co., Inc., Rahway

    Google Scholar 

  • Djavanshir D, Abolghasem J, Jamal N (2008) Ultrasonic assisted SPME coupled with GC and GC–MS using pencil lead as a fiber for monitoring the organic volatile impurities of ceftazidime. J Chromatogr Sci 46(8):680–685. https://doi.org/10.1093/chromsci/46.8.680

    Article  Google Scholar 

  • European Pharmacopoeia (EP) Ed 9.6 (2018) General Chapter 2.4.24. Identification and control of residual solvents. Strasbourg, France, Council of Europe

  • International Agency for Research on Cancer (IARC) (2012) Monograph 100F, pp 249–294

  • International Conference on Harmonization (ICH) of Technical Requirements for Registration of Pharmaceuticals for Human Use, Topic M7 (R1) (2017) Assessment and control of DNA reactive (mutagenic) impurities in pharmaceuticals to limit potential carcinogenic risk

  • International Conference on Harmonization (ICH) of Technical Requirements for Registration of Pharmaceuticals for Human Use, Topic Q2A and Q2B (R6) (2005) Guideline on validation of analytical procedures

  • International Conference on Harmonization (ICH) of Technical Requirements for Registration of Pharmaceuticals for Human Use, Topic Q3C (R6) (2016) Guideline for residual solvents

  • Jörg F, Ulrich G, Thomas AS (2005) Toluene in Ullmann’s encyclopedia of industrial chemistry. Wiley-VCH, Weinheim

    Google Scholar 

  • Katharina S, Ulrich O, Thomas B, Werner W (2013) Changes in recovery due to drug product matrix ageing as a source of mass imbalances. J Pharm Biomed Anal 74(23):117–125. https://doi.org/10.1016/j.jpba.2012.10.014

    Article  CAS  Google Scholar 

  • Nakagawa H, Nemoto O, Igarashi A, Nagata T (2017) Efficacy and safety of topical JTE-052, a Janus kinase inhibitor, in Japanese adult patients with moderate-to-severe atopic dermatitis: a phase II, multicentre, randomized, vehicle-controlled clinical study. Br J Dermatol 178(2):424–432. https://doi.org/10.1111/bjd.16014

    Article  CAS  Google Scholar 

  • Paul SC, Walters WP (2014) Acidic and basic drugs in medicinal chemistry: a perspective. J Med Chem 57(23):9701–9717. https://doi.org/10.1021/jm501000a

    Article  CAS  Google Scholar 

  • Santosh K, Neetu S, Ram P (2010) Anhydrous ethanol: a renewable source of energy. Renew Sustain Energy Rev 14(7):1830–1844. https://doi.org/10.1016/j.rser.2010.03.015

    Article  CAS  Google Scholar 

  • Sebrina W (2012) Basic technology and tools in chemical engineering field. World Technologies, Amsterdam

    Google Scholar 

  • Tanimoto A, Ogawa Y, Oki C, Kimoto Y, Nozawa K, Amano W, Noji S, Shiozaki M, Matsuo A, Shinozaki Y, Matsushita M (2015) Pharmacological properties of JTE-052: a novel potent JAK inhibitor that suppresses various inflammatory responses in vitro and in vivo. Inflamm Res 64(1):41–51. https://doi.org/10.1007/s00011-014-0782-9

    Article  CAS  PubMed  Google Scholar 

  • Tanimoto A, Shinozaki Y, Yamamoto Y, Katsuda Y, Taniai-Riya E, Toyoda K, Kakimoto K, Kimoto Y, Amano W, Konishi N, Hayashi M (2018) A novel JAK inhibitor JTE-052 reduces skin inflammation and ameliorates chronic dermatitis in rodent models: comparison with conventional therapeutic agents. Exp Dermatol 27(1):22–29. https://doi.org/10.1111/exd.13370

    Article  CAS  PubMed  Google Scholar 

  • Tien DH, Manishkumar DJ, Mark AS, Jared LA (2012) Selective extraction of genotoxic impurities and structurally alerting compounds using polymeric ionic liquid sorbent coatings in solid-phase microextraction: alkyl halides and aromatics. J Chromatogr A 1240(1):29–44. https://doi.org/10.1016/j.chroma.2014.07.099

    Article  CAS  Google Scholar 

  • Tien DH, Peter MY, Nik PC, Jin W, Jared LA, Qiqing Z (2014) Determination of trace level genotoxic impurities in small molecule drug substances using conventional headspace gas chromatography with contemporary ionic liquid diluents and electron capture detection. J Chromatogr A 1361(26):217–228. https://doi.org/10.1016/j.chroma.2014.07.099

    Article  CAS  Google Scholar 

  • United States Pharmacopoeia (USP) 41 NF-36 (2018) General chapter 467 residual solvents. Rockville

  • World Health Organization (WHO) (2010) Exposure to benzene, a major public health concern

  • Wu-Hsun C, Harold HK (1994) Methanol production and use. Marcel Dekker, New York

    Google Scholar 

  • Yue H, Nicholson SJ, Young JD, Hsieh D, Ketner RJ, Hall RG, Sackett J, Banks EC, Castoro JA, Randazzo ME (2015) Development of a control strategy for benzene impurity in HPMCAS-stabilized spray-dried dispersion drug products using a science-based and risk-based approach. Pharm Res 32(8):2636–2648. https://doi.org/10.1007/s11095-015-1649-7

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We would like to show our greatest appreciation to Takashi Inaba and Hideto Uehara who provided carefully considered feedback and valuable comments. We would also like to thank our colleagues who gave us invaluable comments and warm encouragements.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Shinkichi Nomura.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nomura, S., Ito, Y., Takegami, S. et al. Development and validation of an assay method for benzene in the delgocitinib drug substance using conventional HPLC. Chem. Pap. 73, 673–681 (2019). https://doi.org/10.1007/s11696-018-0608-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11696-018-0608-2

Keywords

Navigation